Atlas Trials

Ponatinib in Advanced NSCLC w/ RET Translocations

Clinical trial NCT01813734 · COMPLETED

Trial details

NCT number
NCT01813734
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2013-09-01
Primary completion
2018-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.